share_log

LevelJump Announces That It Will Be Delayed in Filing Year-End Reporting Documents

LevelJump Announces That It Will Be Delayed in Filing Year-End Reporting Documents

LevelJump宣布将推迟提交年终报告文件
newsfile ·  04/15 22:33

Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces today that it anticipates the filing of its annual financial statements, management's discussion and analysis and related officer certifications for the financial year ended December 31, 2023 (collectively, the "Annual Filings") will be delayed beyond the required filing deadline under Parts 4 and 5 of National Instrument 51-102 - Continuous Disclosure Obligations and pursuant to National Instrument 52-109 - Certification of Disclosure in Issuer's Annual and Interim Filings, being April 29, 2024 (the "Filing Deadline").

安大略省多伦多--(Newsfile Corp.-2024 年 4 月 15 日)- LevelJump 医疗保健公司(多伦多证券交易所股票代码:JUMP)(“LevelJump” 或 “公司”) 今天宣布,预计截至2023年12月31日的财政年度的年度财务报表、管理层的讨论和分析以及相关官员认证(统称 “年度申报”)的提交将推迟到国家仪器51-102——持续披露义务第4和5部分规定的申报截止日期,以及根据国家仪器52-109——发行人年度和中期申报的披露证明,即2024年4月29日(“申报”)截止日期”)。

In light of a recent change in the Company's auditor to Kreston GTA LLP (see the Company's Notice of Change of Auditors filed on SEDAR+ dated March 19, 2024) and an exceptionally large amount of audit work related to the Company's Alberta acquisitions during the 4th quarter (see the Company's news release dated October 11, 2023), the Company has determined that it will not be able to complete the audit and file the Annual Filings by the Filing Deadline. The Company intends to work closely with its auditor and expects to file the Annual Filings as soon as possible, and in any event no later than June 28, 2024.

鉴于公司审计师最近变更为Kreston GTA LLP(见公司于2024年3月19日在SEDAR+上提交的审计员变更通知),以及与公司在第四季度收购艾伯塔省相关的大量审计工作第四 季度(见公司2023年10月11日的新闻稿),公司已确定无法在申报截止日期之前完成审计和提交年度申报。该公司打算与其审计师密切合作,并希望尽快提交年度申报,无论如何都不迟于2024年6月28日。

The Company is providing this default announcement in accordance with National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"). The Company has made an application to the Ontario Securities Commission, as principal regulator of the Company, for a management cease trade order ("MCTO") under NP 12-203 in respect of the anticipated default regarding the Annual Filings. The granting of the MCTO is at the discretion of the Ontario Securities Commission. The issuance of the MCTO generally will not affect the ability of persons who have not been directors, officers or insiders of the Company to trade in their securities. In the event that the MCTO is granted, it will be in effect until the default is remedied.

公司根据国家政策12-203——管理层停止交易令(“NP 12-203”)发布此默认公告。该公司已向作为公司主要监管机构的安大略省证券委员会申请根据NP 12-203发布管理停止交易令(“MCTO”),内容涉及年度申报的预期违约情况。MCTO的授予由安大略省证券委员会自行决定。MCTO的发行通常不会影响非公司董事、高级管理人员或内部人士交易其证券的能力。如果授予 MCTO,它将一直有效,直到默认值得到纠正。

The Company intends to follow the provisions of the Alternative Information Guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases, for as long as the Company remains in default. The Company confirms as of the date of this news release that there is no insolvency proceeding against it and there is no other material information concerning the affairs of the Company that has not been generally disclosed.

只要公司继续违约,公司就打算遵守NP 12-203中规定的替代信息指南的规定,包括以新闻稿的形式每两周发布违约状态报告。截至本新闻稿发布之日,公司确认没有对其进行破产程序,也没有其他未被普遍披露的有关公司事务的重大信息。

About LevelJump Healthcare

关于 LevelJump

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

LevelJump Healthcare Corp.(多伦多证券交易所股票代码:JUMP)通过其远程放射学部门为客户医院和成像中心提供远程医疗解决方案,并通过其诊断中心提供面对面的放射学服务。JUMP主要专注于急诊和急诊患者的重症监护,在我们服务的社区中建立完整的关系。

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

代表董事会
LEVELJUMP 医疗保健公司

Mitchell Geisler
Chief Executive Officer

米切尔·盖斯勒
首席执行官

Caitlin-Robyn Densmore
Business Development Manager
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568

Caitlin-Robyn Densmore
业务发展经理
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

关于前瞻性信息的警示声明

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

本新闻稿包含与公司业务计划和公司行业前景有关的适用证券法所指的 “前瞻性信息”。尽管根据其高管和董事的经验、当前状况和预期的未来发展以及其他被认为适当的因素,公司认为,这些前瞻性信息中反映的预期是合理的,但不应过度依赖这些期望,因为公司无法保证这些预期会被证明是正确的。实际结果和发展可能与这些陈述所设想的结果和进展存在重大差异。本新闻稿中的声明自本新闻稿发布之日起作出,除适用的证券法要求外,公司不承担任何责任对其进行更新或修改以反映新的事件或情况。公司没有义务评论第三方对公司、Canadian Teleradiology Services, Inc.、其证券或各自的财务或经营业绩(如适用)的分析、预期或声明。

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

交易所及其监管服务提供商(该术语在联交所政策中定义)均不对本新闻稿的充分性或准确性承担责任。

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

所发行的证券过去和将来都没有根据经修订的1933年《美国证券法》(“美国证券法”)或任何美国州证券法进行注册,也不得在美国发行或出售,也不得向未经注册或适用《美国证券法》和适用的美国州证券法注册要求豁免的美国人发行或出售,也不得为美国人的账户或利益进行发行或出售。本新闻稿不构成在美国或任何其他司法管辖区出售证券的要约或要求购买证券的要约。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发